TOP2A and EZH2 provide early detection of an aggressive prostate cancer subgroup

PURPOSE: Current clinical parameters do not stratify indolent from aggressive prostate cancer (PCa). Aggressive PCa, defined by the progression from localized disease to metastasis, is responsible for the majority of PCa-associated mortality. Recent gene expression profiling has proven successful in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Labbé, David P., Sweeney, Christopher J., Brown, Myles, Galbo, Phillip, Rosario, Spencer, Wadosky, Kristine M., Ku, Sheng-Yu, Sjöström, Martin, Alshalalfa, Mohammed, Erho, Nicholas, Davicioni, Elai, Karnes, R. Jeffrey, Schaeffer, Edward M., Jenkins, Robert B., Den, Robert B., Ross, Ashley E., Bowden, Michaela, Huang, Ying, Gray, Kathryn P., Feng, Felix Y., Spratt, Daniel E., Goodrich, David W., Eng, Kevin H., Ellis, Leigh
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5690819/
https://ncbi.nlm.nih.gov/pubmed/28899973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-17-0413
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados